Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosis - eBioMedicine
Vaccines | Free Full-Text | Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study - ScienceDirect
Response to COVID-19 boosters in seronegative multiple sclerosis patients
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point | Neurology and Therapy
Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry - Multiple Sclerosis and Related Disorders
Vaccination and immunotherapies in neuroimmunological diseases | Nature Reviews Neurology
New Data Show COVID-19 Vaccine Does Not Raise Stroke Risk
:max_bytes(150000):strip_icc()/brano-QSuou3VAtf4-unsplash-de657fc5880046b493909ea2e02262dc.jpeg "COVID-19 Booster Shots: Are They Variant-Specific?")
COVID-19 Booster Shots: Are They Variant-Specific?
Multiple Sclerosis Patients Show T-Cell Response to COVID-19 Vaccines
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis | Journal of Neurology, Neurosurgery & Psychiatry
COVID-19, Vaccinations & Multiple Sclerosis - Practical Neurology
Factsheet: COVID-19 Vaccine Guidance for People Living with Multiple Sclerosis (English, Spanish) | Vaccine Resource Hub
Frontiers | Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland
Breakthrough COVID-19 in Patients With Multiple Sclerosis: Snapshot From One Data Registry – Consult QD
Frontiers | Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
COVID-19 vaccination guidance for persons with Multiple Sclerosis (MS) | Multiple Sclerosis Society of NZMultiple Sclerosis Society of NZ
Vaccines | Free Full-Text | Neurological Disorders following COVID-19 Vaccination
COVID-19 booster jabs for people with MS this autumn | MS Society
T-cell response to Omicron after an mRNA COVID vaccine booster
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic | Journal of Neurology, Neurosurgery & Psychiatry
Queen Mary University of London
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study - The Lancet Regional Health – Europe
COVID-19 mRNA vaccines: Platforms and current developments: Molecular Therapy
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study - The Lancet Regional Health – Europe
COVID-19, Vaccinations & Multiple Sclerosis - Practical Neurology
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies - Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, Mark Dolev,
